[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"feeding-behavior\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:feeding-behavior":34},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,59,89,119,153,192,222],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":44,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100637347","phase-3-a-study-of-orforglipron-ly3502970-in-participants-with-type-2-diabetes-who-observe-ramadan-fasting-100637347",false,"NCT07613307","A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting","A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants With Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM)","ACHIEVE-RAM","Inclusion Criteria:\n\n* Have a clinical diagnosis of T2D based on the World Health Organization (WHO) classification or other locally applicable diagnostic standards.\n* Have an HbA1c value of at least 7.0% (53 millimoles per mole (mmol\u002Fmol)) to less than 9.5% (91 mmol\u002Fmol) at screening.\n* Intend to be compliant with the fast during the Ramadan period.\n* Have had stable body weight self-reported change of 5 kilograms (kg) or lower during the 90 days prior to screening.\n* Have body mass index (BMI) of 25 kilograms per meter square (kg\u002Fm2) or higher at screening.\n\nExclusion Criteria:\n\n* Have any form of diabetes other than T2D, including type 1 diabetes (T1D), gestational diabetes, latent autoimmune diabetes, maturity-onset diabetes of the young, and medication-induced diabetes\n* Have a family (first-degree relative) or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.\n* Have a history of chronic or acute pancreatitis any time prior to screening\n* Have evidence of a significant, uncontrolled endocrine abnormality, for example, thyrotoxic or adrenal crises, in the opinion of the investigator\n* Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy for less than 5 years.\n* Have a history of cholecystectomy (surgically removed gallbladder)\n* Have New York Heart Association Functional Classification IV congestive heart-failure.","ALL","18 Years","65 Years",{"count":21,"type":22},130,"ESTIMATED","INTERVENTIONAL",[25],"PHASE3","The purpose of this study is to test the efficacy and safety of orforglipron in participants with T2D (type 2 diabetes) who participate in fasting during Ramadan. For each participant, the study will last up to 48 weeks with a minimum of 7 in clinic visits and 4 virtual visits.",[28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43],"Diabetes Mellitus, Type 2","Diabetes Melletus","Glucose Metabolism Disorders","Metabolic Disorders","Nutritional and Metabolic Diseases","Endocrine System Diseases","Feeding Behavior","Behavior","Fasting","Glucagon-Like Peptide-1 Receptor","Glucagon-Like Peptide Receptors","Receptors, G-Protein-Coupled","Receptors, Cell Surface","Membrane Proteins","Proteins","Receptors, Peptide",[45,36],"Ramadan","NOT_YET_RECRUITING","2026-06-18",{"date":49,"type":50},"2026-06-23","ACTUAL",{"date":52,"type":22},"2026-07",{"date":54,"type":22},"2027-05",{"name":56,"class":57},"Eli Lilly and Company","INDUSTRY",37,{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":4,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":17,"minAge":18,"maxAge":67,"enrollmentInfo":68,"targetDuration":4,"studyType":23,"phases":70,"briefSummary":72,"conditions":73,"keywords":4,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":88},"100507005","integrating-food-rx-with-best-feeding-practices-with-efnep-100507005","NCT05881759","Integrating Food Rx With Best Feeding Practices With EFNEP","Integrating Food Rx With Best Feeding Practices for Chronic Disease Prevention Among EFNEP Participants","Inclusion Criteria:\n\n* Living in Harris or Fort Bend counties\n* being a parent of a child 4-8 years old\n* ability to speak in English or Spanish\n* have ready access to a telephone\n* have access to the Internet with a smart phone, a tablet, a laptop, or a desktop computer\n\nExclusion Criteria:\n\n* parents of children with disabilities and\u002For those on prescription medications that affect weight and\u002For appetite\n* parents who are not able to complete self-report questionnaires",true,"64 Years",{"count":69,"type":22},375,[71],"NA","To assess feasibility and acceptability of of integrating Food Rx and Best Feeding Practices with EFNEP participants via a pilot study.",[74,75,76,34],"Dietary Habits","Childhood Obesity","Food Selection","RECRUITING","2026-06-01",{"date":80,"type":50},"2026-06-02",{"date":82,"type":50},"2024-01-15",{"date":84,"type":22},"2027-03-31",{"name":86,"class":87},"Baylor College of Medicine","OTHER",1,{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":66,"sex":96,"minAge":18,"maxAge":4,"enrollmentInfo":97,"targetDuration":4,"studyType":23,"phases":99,"briefSummary":100,"conditions":101,"keywords":106,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":115,"leadSponsor":117,"locationsCount":88},"100637032","effects-of-mindful-eating-on-female-nutrition-students-100637032","NCT07573410","Effects of Mindful Eating on Female Nutrition Students","Efficacy of a Mindful Eating Intervention on Eating Behavior, Body Image, and Mental Health in Female Nutrition Students: a Pilot Randomized Clinical Trial","Inclusion Criteria:\n\n* Female gender\n* Active enrollment in the Nutrition undergraduate program at the time of data collection\n* Agreement to participate in the study\n\nExclusion Criteria:\n\n* Diagnosis of severe cognitive or mental disorders; Regular practice (at least once a week in the last six months) of meditation, yoga, or mindfulness\n* Regular practice (at least once a week in the last six months) of meditation, yoga, or mindfulness","FEMALE",{"count":98,"type":22},88,[71],"The goal of this pilot randomized clinical trial is to evaluate the efficacy of a mindful eating intervention (\"Eat for Life\") on eating behavior, body image, and mental health in female nutrition students. The main questions it aims to answer are: Does a mindful eating intervention reduce disordered eating behaviors in female nutrition students? Does the intervention improve body appreciation, mindfulness levels, and mental health?\n\nResearchers will compare an active control group receiving nutritional guidance to an intervention group participating in the \"Eat for Life\" mindful eating program to see if the mindful eating intervention reduces disordered eating behaviors and improves overall psychological well-being and body appreciation.\n\nParticipants will: Complete online questionnaires evaluating eating behavior, mindfulness, mental health, and body image at three distinct time points: before the intervention (baseline), post-intervention, and at a 3-month follow-up.\n\nIf assigned to the intervention group, attend 12 weekly face-to-face mindful eating sessions lasting approximately two hours each. If assigned to the active control group, receive weekly informative leaflets via WhatsApp with nutritional guidance based on the Dietary Guidelines for the Brazilian Population for 12 weeks",[102,103,34,104,105],"Mental Health","Body Image","Feeding and Eating Disorders","Stress and Anxiety",[107,108,109,110],"mindful eating","feeding behavior","Students","mental health","2026-05-06",{"date":113,"type":50},"2026-05-11",{"date":78,"type":22},{"date":116,"type":22},"2027-12-01",{"name":118,"class":87},"Federal University of Uberlandia",{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":124,"acronym":4,"eligibilityCriteria":125,"healthyVolunteers":66,"sex":17,"minAge":18,"maxAge":126,"enrollmentInfo":127,"targetDuration":4,"studyType":23,"phases":129,"briefSummary":130,"conditions":131,"keywords":136,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":147,"completionDateStruct":149,"leadSponsor":151,"locationsCount":88},"100623151","food-intake-related-brain-and-metabolic-responses-in-obesity-100623151","NCT07392905","Food Intake-Related Brain and Metabolic Responses in Obesity","Association Between Food Intake-Related Brain Functional Patterns and Metabolic Profiles in Patients With Obesity: A Randomized Crossover Trial","Inclusion Criteria:\n\nObese participants:\n\n1. BMI ≥ 28 kg\u002Fm²;\n2. Age 18-40 years;\n3. Any gender;\n4. Right-handed.\n\nHealthy control participants:\n\n1. BMI 18.5-23.9 kg\u002Fm²;\n2. Age 18-40 years;\n3. Any gender;\n4. Right-handed.\n\nExclusion Criteria:\n\n1. Diabetes mellitus;\n2. Contraindications or allergies to any ingredient in the standardized meal or macronutrient challenges used in this study;\n3. Central nervous system disorders (e.g., traumatic brain injury, acute cerebral infarction, epilepsy) or psychiatric disorders (e.g., depression, schizophrenia); use of medications acting on the central nervous system within the past 3 months or long-term use;\n4. Severe impairment of liver, kidney, heart, or gastrointestinal function, including alanine aminotransferase (ALT) and\u002For aspartate aminotransferase (AST) levels \\>2 times the upper limit of normal; estimated glomerular filtration rate (eGFR) \\\u003C45 mL\u002Fmin\u002F1.73 m² calculated by the CKD-EPI equation; history of unstable angina or myocardial infarction within the past 3 months, or heart failure classified as New York Heart Association (NYHA) class II or higher; history of gastrointestinal stoma, bowel resection, intestinal obstruction, or peptic ulcer disease;\n5. Contraindications to MRI, such as implanted metallic devices or claustrophobia;\n6. Pregnancy or lactation;\n7. Participation in another clinical trial currently or within the past 3 months; use of nutritional supplements within the past 3 months or long-term use;\n8. History of prior metabolic\u002Fbariatric surgery;\n9. Use of antibiotics or probiotics within the past 1 month;\n10. Use of medications affecting metabolism or causing weight loss within the past 1 month; body weight fluctuation exceeding 3 kg during the month prior to screening;\n11. Unusual dietary habits; daily alcohol intake \\>40 grams, smoking \\>10 cigarettes per day, or coffee consumption ≥2 cups per day.","40 Years",{"count":128,"type":22},60,[71],"This study is a prospective, single-center, randomized, controlled, crossover intervention trial. A total of 60 participants, including 30 patients with obesity and 30 healthy controls, will be enrolled. Each participant will receive an isocaloric liquid meal challenge (glucose, fat, or protein) on three separate experimental days, with a washout period of at least 7 days between visits to eliminate carryover effects from the previous intervention. The primary objective is to investigate the association between brain functional patterns and plasma metabolic profiles following the ingestion of different macronutrients in patients with obesity, aiming to uncover potential neuro-metabolic imbalance features.",[132,133,134,34,135],"Obesity","Brain Function","Metabolomics","Macronutrients",[137,138,139,140,141,142,143],"obesity","macronutrient","fMRI","Cross-over trial","Plasma metabolome","Satiety","Nutrient challenge","2026-01-31",{"date":146,"type":50},"2026-02-06",{"date":148,"type":50},"2025-12-21",{"date":150,"type":22},"2027-09-01",{"name":152,"class":87},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":66,"sex":17,"minAge":161,"maxAge":18,"enrollmentInfo":162,"targetDuration":4,"studyType":23,"phases":164,"briefSummary":165,"conditions":166,"keywords":171,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":191},"100610097","a-sensory-strategy-to-cut-sugary-beverages-in-africanamerican-and-latine-adolescents-100610097","NCT07223151","A Sensory Strategy to Cut Sugary Beverages in African\u002FAmerican and Latine Adolescents","Trading Sugar for Sparkles in Adolescents, A Sensory Approach for Reducing Added Sugar From Sweetened Beverages","SPARKLE","Inclusion Criteria:\n\n* Adolescents ages 12 to 18 who display a \"sweet-liker\" pattern, characterized by a preference for higher concentrations of sugar in beverages, specifically identifying 0.3M (10.3% sucrose) or above as their most liked sample.\n* Have obesity (body mass index \\[BMI\\] \\> 95%). During screening, subjects' height and weight will be measured to calculate BMI, and BMI will be balanced across study arms using stratified randomization.\n* Adolescents must also indicate a willingness to drink study beverages; not currently dieting\u002Fchanging diet.\n\nExclusion Criteria:\n\n* For the primary objective. Exclusion Criteria:\n\n  * Adolescent participant is pregnant, since pregnancy affects taste perception\n  * Participant is allergic or intolerant to the items we are testing.\n\nFor the secondary objective. Exclusion Criteria:\n\n* Adolescent with type 1 or type 2 diabetes (self-declared or detected at screening visit through fasting glucose)\n* Currently consume unsweetened, sparkling water two or more times per week.\n* Adolescent participant is pregnant, since pregnancy affects taste perception\n* Participant is allergic or intolerant to the items we are testing.\n* Allergic or intolerant to the items that we are testing.","12 Years",{"count":163,"type":22},63,[71],"The goal of this clinical trial is to test whether replacing sugary sodas with unsweetened, flavored sparkling waters can reduce added sugar intake and improve health in Black\u002FAfrican American and Latine adolescents with obesity who prefer sweet-tasting beverages. The main questions it aims to answer are:\n\n* Does replacing sugary sodas with water change liking for sugary drinks, and water?\n* Do shifts in liking for sweetness lead to improved diet quality and cardiometabolic health?\n\nResearchers will compare replacing sugary sodas with one of three alternative beverages: unsweetened sparkling water, plain water, and beverages with gradually reduced sugar to determine which strategy is most effective.\n\nParticipants will:\n\n* Replace sugary sodas with study drinks for 4 weeks\n* Complete taste tests to measure their liking for and sensory experience of sweetness over 8-weeks\n* Provide dietary recalls, body measurements, and blood samples over 8-weeks",[167,168,169,170,34],"Obesity, Adolescent","Dietary Sugars","Taste Perception","Insulin Resistance",[132,172,173,169,170,174,175,176,177,178,179,180,181],"Adolescent","Sugar-Sweetened Beverages","Sweet Taste Preference","Latine Youth","African American Youth","Dietary Intervention","Beverage Replacement","Sugar Reduction","Sensory Evaluation","Randomized Controlled Trial","2025-10-29",{"date":184,"type":50},"2025-10-31",{"date":186,"type":50},"2025-07-25",{"date":188,"type":22},"2027-06",{"name":190,"class":87},"Nana Gletsu Miller",3,{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":199,"enrollmentInfo":200,"targetDuration":4,"studyType":202,"phases":4,"briefSummary":203,"conditions":204,"keywords":208,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":213,"lastUpdatePostDateStruct":214,"startDateStruct":216,"completionDateStruct":218,"leadSponsor":220,"locationsCount":191},"100515140","predictors-of-weight-loss-and-metabolic-health-after-bariatric-surgery-100515140","NCT05987631","Predictors of Weight Loss and Metabolic Health After Bariatric Surgery","Preoperative Predictors of Weight Loss and Improved Metabolic Health After Bariatric Surgery","Inclusion Criteria:\n\n* Ability to provide informed consent\n* Patient is ≥ 18 and ≤ 75 years old\n* BMI ≥ 40 kg\u002Fm2 or ≥ 35 kg\u002Fm2 with obesity related comorbidity\n* Scheduled for primary bariatric procedure: Roux-en-Y gastric bypass (RYGB) or Sleeve Gastrectomy (SG)\n* Stable weight 3 months prior to inclusion weight (\\\u003C10% change in body weight for 3 months prior to assessments)\n\nIn order to be eligible to participate in the subgroup of this study, we will use the following inclusion criteria:\n\n* Ability to provide informed consent\n* Patient is ≥ 18 and ≤ 75 years old\n* BMI ≥ 40 kg\u002Fm2 or ≥ 35 kg\u002Fm2 with obesity related comorbidity\n* Patients scheduled for RYGB\n* Patients who are insulin resistant (impaired fasting glucose (\\> 5.6 mmol\u002FL) or fasting insulin \\> 74 pmol\u002FL)\n* Postmenopausal women (to prevent bias due to the effect of sex hormones on insulin sensitivity)\n\nExclusion Criteria:\n\n* Any actual medical condition except for obesity related health issues or well treated hypothyroidism\n* Pregnancy anticipated in the first two years following surgery\n\nA potential subject who meet the following criteria will be excluded from participation in the subgroup of this study:\n\n* Coagulation disorders and\u002For use anticoagulants\n* Use of any medication except for statins, antihypertensives (except for Angiotensine converting enzyme (ACE)- or angiotensin receptor blockers) and thyroid hormone\n* Diabetes mellitus type 2","75 Years",{"count":201,"type":22},1200,"OBSERVATIONAL","In this prospective study the investigators aim to identify preoperative predictors of improvement of metabolic health and weight loss after bariatric surgery focusing on inflammation, insulin sensitivity (in a subgroup of patients), glucoregulatory determinants, psychological traits, feeding behavior characteristics and cardiorespiratory fitness",[205,206,207,34],"Obesity, Morbid","Insulin Sensitivity","Bariatric Surgery Candidate",[132,209,210,211,212],"Bariatric Surgery","Metabolic health","Weight loss","Predictors","2023-08-04",{"date":215,"type":50},"2023-08-14",{"date":217,"type":50},"2023-01-19",{"date":219,"type":22},"2027-08-31",{"name":221,"class":87},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",{"id":223,"slug":224,"hasResults":11,"nctId":225,"briefTitle":226,"officialTitle":226,"acronym":227,"eligibilityCriteria":228,"healthyVolunteers":66,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":229,"targetDuration":4,"studyType":202,"phases":4,"briefSummary":231,"conditions":232,"keywords":4,"overallStatus":77,"whyStopped":4,"lastUpdateSubmitDate":236,"lastUpdatePostDateStruct":237,"startDateStruct":239,"completionDateStruct":241,"leadSponsor":243,"locationsCount":88},"100302478","the-jiaxing-birth-cohort-in-china-100302478","NCT03217656","The Jiaxing Birth Cohort in China","JBC","Inclusion Criteria:\n\n1. Pregnant women came to clinic visit at one of the local hospitals during pregnancy at Jiaxing area\n2. Pregnant women were followed up during pregnancy and their children were born alive at local hospital or clinics\n\nExclusion Criteria:\n\n1. Those who did not want to participant\n2. The infant was dead at the birth\n3. Those pregnant mothers who dropped out during follow-up at pregnancy or moved out of the Jiaxing area",{"count":230,"type":22},500000,"The Jiaxing Birth Cohort (JBC) is the largest prospective cohort study to explore prenatal risk factors, early life feeding practice and growth pattern\u002F adiposity in Chinese children.Between 1999 and 2013, 338 413 mother-child pairs were recruited in Jiaxing area in south-east China.Children of the recruited women were followed up at 1-2, 3, 6, 9 and 12 months of age, and subsequently followed up every 6 months to 36 months of age (toddler stage), and every year to 6-7 years of age before they went to school (pre-school stage). Follow-up rate was 70.8% at the toddler stage and 68.9% at the pre-school stage up to June 2013.",[75,233,234,235,34],"Anemia","Pregnancy Complications","Pregnancy; Hypertension","2018-01-18",{"date":238,"type":50},"2018-01-23",{"date":240,"type":50},"1999-01",{"date":242,"type":22},"2029-01",{"name":244,"class":87},"Zhejiang University"]